A module to convert spectral to narrowband snow albedo for use in climate models: SNOWBAL v1.2
GEOSCIENTIFIC MODEL DEVELOPMENT
Authors: van Dalum, Christiaan T.; van de Berg, Willem Jan; Libois, Quentin; Picard, Ghislain; van den Broeke, Michiel R.
Abstract
Snow albedo schemes in regional climate models often lack a sophisticated radiation penetration scheme and generally compute only a broadband albedo. Here, we present the Spectral-to-NarrOWBand ALbedo module (SNOWBAL, version 1.2) to couple effectively a spectral albedo model with a narrowband radiation scheme. Specifically, the Two-streAm Radiative TransfEr in Snow model (TARTES) is coupled with the European Centre for Medium-Range Weather Forecasts (ECMWF) Integrated Forecast System (IFS), cycle 33R1, atmospheric radiation scheme based on the Rapid Radiation Transfer Model, which is embedded in the Regional Atmospheric Climate Model version 2.3p2 (RACMO2). This coupling allows to explicitly account for the effect of clouds, water vapor, snow impurities and snow metamorphism on albedo. Firstly, we present a narrowband albedo method to project the spectral albedos of TARTES onto the 14 spectral bands of the IFS shortwave radiation scheme using a representative wavelength (RW) for each band. Using TARTES and spectral downwelling surface irradiance derived with the DIScrete Ordinate Radiative Transfer atmospheric model, we show that RWs primarily depend on the solar zenith angle (SZA), cloud content and water vapor. Secondly, we compare the TARTES narrowband albedo, using offline RACMO2 results for south Greenland, with the broadband albedo parameterizations of Gardner and Sharp (2010), currently implemented in RACMO2, and the multi-layered parameterization of Kuipers Munneke et al. (2011, PKM). The actual absence of radiation penetration in RACMO2 leads on average to a higher albedo compared with TARTES narrowband albedo. Furthermore, large differences between the TARTES narrowband albedo and PKM and RACMO2 are observed for high SZA and clear-sky conditions, and after melt events when the snowpack is very inhomogeneous. This highlights the importance of accounting for spectral albedo and radiation penetration to simulate the energy budget of the Greenland ice sheet.
Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
PHARMACOGENOMICS JOURNAL
Authors: Graziano, F.; Ruzzo, A.; Giacomini, E.; Ricciardi, T.; Aprile, G.; Loupakis, F.; Lorenzini, P.; Ongaro, E.; Zoratto, F.; Catalano, V.; Sart, D.; Rulli, E.; Cremolini, C.; De Nictolis, M.; De Maglio, G.; Falcone, A.; Fiorentinil, G.; Magnani, M.
Abstract
Production of lactate even in the presence of sufficient levels of oxygen (aerobic glycolysis) seems the prevalent energy metabolism pathway in cancer cells. The analysis of altered expression of effectors causing redirection of glucose metabolism would help to characterize this phenomenon with possible therapeutic implications. We analyzed mRNA expression of the key enzymes involved in aerobic glycolysis in normal mucosa (NM), primary tumor (PT) and liver metastasis (LM) of colorectal cancer (CRC) patients (pts) who underwent primary tumor surgery and liver metastasectomy. Tissues of 48 CRC pts were analyzed by RT-qPCR for mRNA expression of the following genes: hexokinase-1 (HK-1) and 2 (HK-2), embryonic pyruvate kinase (PKM-2), lactate dehydrogenase-A (LDH-A), glucose transporter-1 (GLUT-1), voltage-dependent anion-selective channel protein-1 (VDAC-1). Differences in the expression of the candidate genes between tissues and associations with clinical/pathologic features were studied. GLUT-1, LDH-A, HK-1, PKM-2 and VDAC-1 mRNA expression levels were significantly higher in PT/LM tissues compared with NM. There was a trend for higher expression of these genes in LM compared with PT tissues, but differences were statistically significant for LDH-A expression only. RAS mutation-positive disease was associated with high GLUT-1 mRNA expression levels only. Right-sided colon tumors showed significantly higher GLUT-1, PKM-2 and LDH-A mRNA expression levels. High glycolytic profile was significantly associated with poor prognosis in 20 metastatic, RAS-mutated pts treated with first-line chemotherapy plus Bevacizumab. Altered expression of effectors associated with upregulated glucose uptake and aerobic glycolysis occurs in CRC tissues. Additional analyses are warranted for addressing the role of these changes in anti-angiogenic resistance and for developing novel therapeutics.